| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | impaired neutrophil phagocytosis | 1.26e-05 | 14 | 47 | 3 | MP:0002467 | |
| Domain | FN3_dom | 3.27e-06 | 209 | 57 | 7 | IPR003961 | |
| Domain | FN3 | 3.13e-05 | 199 | 57 | 6 | PS50853 | |
| Domain | FN3 | 2.49e-04 | 185 | 57 | 5 | SM00060 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.13e-04 | 14 | 57 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 8.13e-04 | 14 | 57 | 2 | IPR013602 | |
| Domain | DHC_N2 | 8.13e-04 | 14 | 57 | 2 | PF08393 | |
| Domain | AAA_8 | 8.13e-04 | 14 | 57 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 8.13e-04 | 14 | 57 | 2 | IPR011704 | |
| Domain | AAA_5 | 8.13e-04 | 14 | 57 | 2 | PF07728 | |
| Domain | DHC_fam | 9.37e-04 | 15 | 57 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 9.37e-04 | 15 | 57 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 9.37e-04 | 15 | 57 | 2 | PF03028 | |
| Domain | fn3 | 1.51e-03 | 162 | 57 | 4 | PF00041 | |
| Domain | Ricin_B_lectin | 2.62e-03 | 25 | 57 | 2 | PF00652 | |
| Domain | RICIN | 3.29e-03 | 28 | 57 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 3.29e-03 | 28 | 57 | 2 | PS50231 | |
| Pubmed | A homozygous deletion within the carbonic anhydrase-like domain of the Ptprg gene in murine L-cells. | 2.64e-06 | 2 | 57 | 2 | 8453613 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8382771 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 8666668 | ||
| Pubmed | The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells. | 7.91e-06 | 3 | 57 | 2 | 9699672 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 34644148 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 22786769 | ||
| Pubmed | JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation. | 2.63e-05 | 5 | 57 | 2 | 19509332 | |
| Pubmed | 2.72e-05 | 214 | 57 | 5 | 22199357 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 12133952 | ||
| Pubmed | 6.43e-05 | 47 | 57 | 3 | 8812413 | ||
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 31549767 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 28180282 | ||
| Pubmed | Typing recombinant inbred mouse strains for microsatellite markers. | 9.43e-05 | 9 | 57 | 2 | 8507976 | |
| Pubmed | 1.11e-04 | 1168 | 57 | 9 | 19946888 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 12960323 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.18e-04 | 10 | 57 | 2 | 20664521 | |
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 24349473 | ||
| Pubmed | Cand1-Mediated Adaptive Exchange Mechanism Enables Variation in F-Box Protein Expression. | 2.03e-04 | 13 | 57 | 2 | 29499133 | |
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 10230407 | ||
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 18715339 | ||
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 9373155 | ||
| Pubmed | Genome-wide association study of recurrent early-onset major depressive disorder. | 3.12e-04 | 16 | 57 | 2 | 20125088 | |
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 17567809 | ||
| Pubmed | 3.53e-04 | 17 | 57 | 2 | 21435555 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 3.84e-04 | 377 | 57 | 5 | 38117590 | |
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 26426795 | ||
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 21572392 | ||
| Pubmed | 6.53e-04 | 23 | 57 | 2 | 24390425 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 6.64e-04 | 1489 | 57 | 9 | 28611215 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 7.12e-04 | 24 | 57 | 2 | 30190310 | |
| Pubmed | 9.02e-04 | 27 | 57 | 2 | 23096701 | ||
| Pubmed | Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation. | 1.02e-03 | 120 | 57 | 3 | 27565346 | |
| Pubmed | FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability. | 1.27e-03 | 32 | 57 | 2 | 35813202 | |
| Pubmed | Genetic variations in humans associated with differences in the course of hepatitis C. | 1.27e-03 | 32 | 57 | 2 | 15063762 | |
| Pubmed | 1.35e-03 | 33 | 57 | 2 | 19817957 | ||
| Pubmed | Role of inflammation gene polymorphisms on pain severity in lung cancer patients. | 1.35e-03 | 33 | 57 | 2 | 19773451 | |
| Pubmed | 1.43e-03 | 34 | 57 | 2 | 25631876 | ||
| Pubmed | 1.60e-03 | 36 | 57 | 2 | 20811626 | ||
| Pubmed | 1.60e-03 | 36 | 57 | 2 | 24035498 | ||
| GeneFamily | Fibronectin type III domain containing | 8.49e-04 | 160 | 48 | 4 | 555 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.46e-06 | 154 | 56 | 5 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.99e-06 | 164 | 56 | 5 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 4.09e-06 | 190 | 56 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 4.52e-06 | 194 | 56 | 5 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.25e-06 | 200 | 56 | 5 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.25e-06 | 200 | 56 | 5 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.25e-06 | 200 | 56 | 5 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.25e-06 | 200 | 56 | 5 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.25e-06 | 200 | 56 | 5 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.25e-06 | 200 | 56 | 5 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-05 | 136 | 56 | 4 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-05 | 136 | 56 | 4 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Tshz2-Syt2_(Layer_5a,_Entorhinal_cortex,_Tshz1+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.65e-05 | 51 | 56 | 3 | adc73d6909d75ad432aef884dae540b7e48cecd6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.44e-05 | 156 | 56 | 4 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 160 | 56 | 4 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 160 | 56 | 4 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 167 | 56 | 4 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.20e-05 | 170 | 56 | 4 | 98d13dbd76a826e47d55553f9d11f71c043b573e | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.34e-05 | 171 | 56 | 4 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-05 | 173 | 56 | 4 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 173 | 56 | 4 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.41e-05 | 178 | 56 | 4 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 56 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.42e-05 | 184 | 56 | 4 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.60e-05 | 185 | 56 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 8.78e-05 | 186 | 56 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.78e-05 | 186 | 56 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 9.15e-05 | 188 | 56 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 9.15e-05 | 188 | 56 | 4 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.34e-05 | 189 | 56 | 4 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.34e-05 | 189 | 56 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.73e-05 | 191 | 56 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.73e-05 | 191 | 56 | 4 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.73e-05 | 191 | 56 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 9.73e-05 | 191 | 56 | 4 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.73e-05 | 191 | 56 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.73e-05 | 191 | 56 | 4 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.73e-05 | 191 | 56 | 4 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.73e-05 | 191 | 56 | 4 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.73e-05 | 191 | 56 | 4 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.73e-05 | 191 | 56 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 9.73e-05 | 191 | 56 | 4 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.73e-05 | 191 | 56 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.73e-05 | 191 | 56 | 4 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 9.73e-05 | 191 | 56 | 4 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 9.73e-05 | 191 | 56 | 4 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 9.92e-05 | 192 | 56 | 4 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 193 | 56 | 4 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 195 | 56 | 4 | d53585715c7f5827c4f5a6db11cb31857ee9d4f0 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 1.05e-04 | 195 | 56 | 4 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 195 | 56 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Ptgfr_(Postsubiculum)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 73 | 56 | 3 | 27644d9b67ef933af0c77936cabdbd81f05c8562 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Ptgfr_(Postsubiculum)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 73 | 56 | 3 | e97b773931a64f7356f44c6950186f7bbbeb3e8d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.07e-04 | 196 | 56 | 4 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 196 | 56 | 4 | e8db58e82300981f981402618a1befb91f6690fd | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 196 | 56 | 4 | 2cf42b702ea15adfa6bbd86a3c9613271863f86c | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-04 | 197 | 56 | 4 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.10e-04 | 197 | 56 | 4 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-04 | 198 | 56 | 4 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.12e-04 | 198 | 56 | 4 | a3d4b6e4259ded2193d94d2ff6d48cf67214fc35 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-04 | 198 | 56 | 4 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-04 | 198 | 56 | 4 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 56 | 4 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 199 | 56 | 4 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 1.14e-04 | 199 | 56 | 4 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 56 | 4 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 199 | 56 | 4 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 1.14e-04 | 199 | 56 | 4 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 1.14e-04 | 199 | 56 | 4 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 199 | 56 | 4 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.14e-04 | 199 | 56 | 4 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 200 | 56 | 4 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 200 | 56 | 4 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-04 | 200 | 56 | 4 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 1.16e-04 | 200 | 56 | 4 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.16e-04 | 200 | 56 | 4 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-04 | 200 | 56 | 4 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-04 | 200 | 56 | 4 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-04 | 200 | 56 | 4 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 200 | 56 | 4 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-04 | 200 | 56 | 4 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.16e-04 | 200 | 56 | 4 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 6.61e-05 | 7 | 53 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | susceptibility to mononucleosis measurement | 2.64e-04 | 69 | 53 | 3 | EFO_0008403 | |
| Disease | hepatitis B (is_marker_for) | 6.50e-04 | 21 | 53 | 2 | DOID:2043 (is_marker_for) | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder | 1.42e-03 | 31 | 53 | 2 | EFO_0003888, MONDO_0004985 | |
| Disease | sphingomyelin measurement | 1.57e-03 | 278 | 53 | 4 | EFO_0010118 | |
| Disease | visceral adipose tissue measurement | 1.70e-03 | 481 | 53 | 5 | EFO_0004765 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAVLVYWRGCNKIKS | 756 | P23470 | |
| QAQIKGAAWYLCLAL | 191 | Q8N8Q1 | |
| CRKGNVVLAQLLIWY | 496 | Q8TF27 | |
| NVCLLEAYNWVKARR | 131 | O95147 | |
| LKGCIVWLDVINHLY | 1391 | Q86UQ4 | |
| ALACSKELWILNRYL | 831 | P15144 | |
| NGLYLWLCQRLFVRK | 331 | Q9ULJ7 | |
| IIDCWIDNIRLVYNK | 86 | Q8NCC3 | |
| AALVCKQWYRLIKGV | 71 | Q6P3S6 | |
| GRQQYVAAPLCLLWL | 341 | Q9BYJ1 | |
| LKVQAQWLYLEPIFC | 906 | Q6ZR08 | |
| WKLCLQGSLYITLIR | 281 | P55160 | |
| LKEGNLVCAQYLWLR | 556 | P50748 | |
| YLLKVNNLIWHVRCL | 81 | Q9UPM6 | |
| YLVWVRCIFNKILLG | 556 | Q8NAT1 | |
| LRLYTCQEWAVVKVQ | 36 | A8MYZ5 | |
| WLCALGLPQYHKQLV | 566 | Q8WXE0 | |
| AGLRRKVLWCLQYIG | 381 | O95800 | |
| IVTLKWIGYICLRNS | 261 | P48551 | |
| VAAPVKWCYGNNVLR | 3211 | Q5VST9 | |
| VLCGVIGLQKWQYDV | 391 | Q08462 | |
| LSVLLYQWILCQGSN | 51 | Q96E93 | |
| QLHLALCWIVRKYDI | 471 | Q07973 | |
| KVLNGICAYLNRHWV | 131 | Q13616 | |
| LQQFNYTWLRLIKCG | 841 | Q7Z7M9 | |
| ARYILVGCWKNLIDT | 861 | Q5TH69 | |
| VYLLINCRNTGPWLK | 261 | P14784 | |
| QSQILLVYCKDGWIG | 316 | Q96DP5 | |
| VQGLNCFWSYLIVKI | 311 | Q6ZMG9 | |
| AVWQRKDILFQICYG | 271 | A6NNE9 | |
| DLVNYQNKCRLIRGW | 1476 | Q14204 | |
| LQWVRGKAYLRNAVV | 41 | Q6IAN0 | |
| LIKVVRGCWILYEQP | 1056 | Q9Y4K1 | |
| QIWIYQEGCIKCRIA | 1626 | Q9Y4K1 | |
| CWNLARGYPKVVTQI | 506 | Q9Y6Q1 | |
| CYNVKRNQWALVAPL | 456 | Q86V97 | |
| VLAQVCKAWRRVLYQ | 116 | Q8N461 | |
| VIEYLLKNQWFVRCQ | 471 | Q5ST30 | |
| QVDLLLGLSYCNGKW | 1786 | O75445 | |
| PWCYVQVGLKLLVQE | 131 | P00749 | |
| LNLPNCWLYQSVKLL | 331 | Q495M3 | |
| CWLYQSVKLLYIAGI | 336 | Q495M3 | |
| FLCYGARLNKWVLQT | 211 | O75783 | |
| ILCWQYLVGKRTVPL | 166 | P08912 | |
| VYSAIWQLCLALIFK | 496 | P51790 | |
| LAGCAVWNIVVIYVL | 236 | Q96Q45 | |
| YWQRVNSKCLFVGIL | 801 | Q99973 | |
| WIIKSNYQGLPVRCV | 176 | P78362 | |
| RKVVQSYVEGLCWVL | 536 | Q9H0D6 | |
| IIQEYKIWCLGNETR | 771 | Q9HCK4 | |
| GYCGTVKRNLLLLAW | 81 | O95859 | |
| QALIQLYARITKLGW | 106 | Q9UIA9 | |
| KNLWYGACVAALVAL | 666 | Q8TEQ8 | |
| WKDRYLLLCQAQLLV | 36 | Q8TD55 | |
| LKISIIGILCYYWLN | 701 | Q6UXY8 | |
| KYIRSFILVLCWILN | 126 | Q9BXE9 | |
| NQGVILSCKRLYRWK | 331 | Q6NT04 | |
| VWFVTLLNILYCVKI | 96 | Q9NYW5 | |
| QRLQKLWVGRLILYS | 36 | Q9C0E8 |